Brand Name: ZYNYZ. Generic Name: (retifanlimab-dlwr). It is used to treat .
ZYNYZ is a programmed death receptor-1 (PD-1)–blocking antibody indicated for the treatment of adult patients with metastatic or recurrent locally advanced Merkel cell carcinoma
| Brand Name: | ZYNYZ |
| Generic Name: | retifanlimab-dlwr |
| Strength: | • Injection: 500 mg/20 mL (25 mg/mL) solution in a single-dose vial |
| Manufacturer: | Incyte Corporation |
| Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “ZYNYZ (retifanlimab-dlwr) Injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.
